OpenURL Connection Search

Select item for more details and to access through your institution.

Neuroendocrine Regulation by the Agouti/Agrp-Melanocortin System.
Published in:
Endocrine Research, 2000, v. 26, n. 4, p. 571, doi. 10.3109/07435800009048572
By:
- Barsh, Greg;
- Gunn, Teresa;
- He, Lin;
- Wilson, Brent;
- Lu, Xinyun;
- Gantz, Ira;
- Watson, Stanley
Publication type:
Article
Randomized, controlled, double-blind trial of taranabant for smoking cessation.
Published in:
Psychopharmacology, 2010, v. 209, n. 3, p. 245, doi. 10.1007/s00213-010-1790-2
By:
- Morrison, Mary;
- Ceesay, Paulette;
- Gantz, Ira;
- Kaufman, Keith;
- Lines, Christopher
Publication type:
Article
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes.
Published in:
Patient Preference & Adherence, 2013, v. 7, p. 937, doi. 10.2147/PPA.S43465
By:
- Hauber, A. Brett;
- Han, Steven;
- Jui-Chen Yang;
- Gantz, Ira;
- Tunceli, Kaan;
- Gonzalez, Juan Marcos;
- Brodovicz, Kimberly;
- Alexander, Charles M.;
- Davies, Michael;
- Iglay, Kristy;
- Qiaoyi Zhang;
- Radican, Larry
Publication type:
Article
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.
Published in:
European Heart Journal, 2023, v. 44, n. 48, p. 5163, doi. 10.1093/eurheartj/ehad639
By:
- Pandey, Ambarish;
- Kolkailah, Ahmed A;
- Cosentino, Francesco;
- Cannon, Christopher P;
- Frederich, Robert C;
- Cherney, David Z I;
- Dagogo-Jack, Samuel;
- Pratley, Richard E;
- Cater, Nilo B;
- Gantz, Ira;
- Mancuso, James P;
- McGuire, Darren K
Publication type:
Article
A Randomized Trial of Lifestyle Modification and Taranabant for Maintaining Weight Loss Achieved With a Low-Calorie Diet.
Published in:
Obesity (19307381), 2010, v. 18, n. 12, p. 2301, doi. 10.1038/oby.2010.67
By:
- Wadden, Thomas A.;
- Fujioka, Ken;
- Toubro, Soren;
- Gantz, Ira;
- Erondu, Ngozi E.;
- Menghui Chen;
- Suryawanshi, Shailaja;
- Carofano, Wendy;
- Johnson-Levonas, Amy O.;
- Shapiro, Deborah R.;
- Kaufman, Keith D.;
- Heymsfield, Steven B.;
- Amatruda, John M.
Publication type:
Article
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691
By:
- Dagogo‐Jack, Samuel;
- Cannon, Christopher P.;
- Cherney, David Z. I.;
- Cosentino, Francesco;
- Liu, Jie;
- Pong, Annpey;
- Gantz, Ira;
- Frederich, Robert;
- Mancuso, James P.;
- Pratley, Richard E.
Publication type:
Article
Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy.
Published in:
Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1640, doi. 10.1111/dom.14385
By:
- Lingvay, Ildiko;
- Greenberg, Michelle;
- Gallo, Silvina;
- Shi, Harry;
- Liu, Jie;
- Gantz, Ira
Publication type:
Article
A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control.
Published in:
Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1242, doi. 10.1111/dom.14331
By:
- Kadowaki, Takashi;
- Seino, Yutaka;
- Kaku, Kohei;
- Okamoto, Taro;
- Kameya, Miho;
- Sato, Asako;
- Hirano, Tomona;
- Oshima, Nobuyuki;
- Gantz, Ira;
- O'Neill, Edward A.;
- Engel, Samuel S.
Publication type:
Article
Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2276, doi. 10.1111/dom.14150
By:
- Pratley, Richard;
- Dagogo‐Jack, Samuel;
- Charbonnel, Bernard;
- Patel, Shrita;
- Hickman, Anne;
- Liu, Jie;
- Tarasenko, Lisa;
- Pong, Annpey;
- Ellison, Misoo C.;
- Huyck, Susan;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
Article
Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 574, doi. 10.1111/dom.13931
By:
- Liu, Jie;
- Patel, Shrita;
- Cater, Nilo B.;
- Wu, Larry;
- Huyck, Susan;
- Terra, Steven G.;
- Hickman, Anne;
- Darekar, Amanda;
- Pong, Annpey;
- Gantz, Ira
Publication type:
Article
Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study
Published in:
Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 781, doi. 10.1111/dom.13574
By:
- Roussel, Ronan;
- Duran‐García, Santiago;
- Zhang, Yilong;
- Shah, Suneri;
- Darmiento, Carolyn;
- Shankar, R. Ravi;
- Golm, Gregory T.;
- Lam, Raymond L. H.;
- O'Neill, Edward A.;
- Gantz, Ira;
- Kaufman, Keith D.;
- Engel, Samuel S.
Publication type:
Article
A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1602, doi. 10.1111/dom.12988
By:
- Gantz, Ira;
- Okamoto, Taro;
- Ito, Yuka;
- Okuyama, Kotoba;
- O'Neill, Edward A.;
- Kaufman, Keith D.;
- Engel, Samuel S.;
- Lai, Eseng
Publication type:
Article
Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 ( DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
Published in:
Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 394, doi. 10.1111/dom.12832
By:
- Goldenberg, Ronald;
- Gantz, Ira;
- Andryuk, Paula J.;
- O'Neill, Edward A.;
- Kaufman, Keith D.;
- Lai, Eseng;
- Wang, Yin Na;
- Suryawanshi, Shailaja;
- Engel, Samuel S.
Publication type:
Article
A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control.
Published in:
Journal of Diabetes, 2016, v. 8, n. 5, p. 701, doi. 10.1111/1753-0407.12351
By:
- Moses, Robert G.;
- Round, Elizabeth;
- Shentu, Yue;
- Golm, Gregory T.;
- O'neill, Edward A.;
- Gantz, Ira;
- Engel, Samuel S.;
- Kaufman, Keith D.;
- Goldstein, Barry J.
Publication type:
Article
796-P: Cardiorenal Outcomes with Ertugliflozin by Baseline Cardiorenal Medications: An Analysis from VERTIS CV.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-796-P
By:
- CHERNEY, DAVID;
- COSENTINO, FRANCESCO;
- MCGUIRE, DARREN K.;
- CHARBONNEL, BERNARD;
- DAGOGO-JACK, SAMUEL;
- PRATLEY, RICHARD E.;
- SHIH, WEICHUNG J.;
- MALDONADO, MARIO;
- PONG, ANNPEY;
- GANTZ, IRA;
- FREDERICH, ROBERT;
- MANCUSO, JAMES P.;
- MASIUKIEWICZ, URSZULA;
- CANNON, CHRISTOPHER P.
Publication type:
Article
786-P: Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-786-P
By:
- DAGOGO-JACK, SAMUEL;
- PRATLEY, RICHARD E.;
- CHERNEY, DAVID;
- CHARBONNEL, BERNARD;
- MCGUIRE, DARREN K.;
- COSENTINO, FRANCESCO;
- SHIH, WEICHUNG J.;
- LIU, JIE;
- FREDERICH, ROBERT;
- MANCUSO, JAMES P.;
- RAJI, ANNASWAMY;
- GANTZ, IRA
Publication type:
Article
785-P: Ertugliflozin (ERTU) Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients with Type 2 Diabetes (T2D): An Analysis From VERTIS CV.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-785-P
By:
- DAGOGO-JACK, SAMUEL;
- FREDERICH, ROBERT;
- CHARBONNEL, BERNARD;
- LIU, JIE;
- CANNON, CHRISTOPHER P.;
- SHI, HARRY;
- MCGUIRE, DARREN K.;
- CHERNEY, DAVID;
- COSENTINO, FRANCESCO;
- SHIH, WEICHUNG J.;
- MASIUKIEWICZ, URSZULA;
- GANTZ, IRA;
- PRATLEY, RICHARD E.
Publication type:
Article
783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-783-P
By:
- CHARBONNEL, BERNARD;
- DAGOGO-JACK, SAMUEL;
- CANNON, CHRISTOPHER P.;
- CHERNEY, DAVID;
- COSENTINO, FRANCESCO;
- MCGUIRE, DARREN K.;
- SHIH, WEICHUNG J.;
- LIU, JIE;
- PONG, ANNPEY;
- GANTZ, IRA;
- FREDERICH, ROBERT;
- MANCUSO, JAMES P.;
- PRATLEY, RICHARD E.
Publication type:
Article
1258-P: Physician Survey on Discontinuing Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) following Insulin Initiation in Patients with Type 2 Diabetes (T2D) in the U.S.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1258-P
By:
- FERNANDES, GAIL;
- JAFFE, DENA H.;
- BEYER, GRACE DIBONAVENTURA;
- MATOS, JOANA E.;
- IGLAY, KRISTY;
- GANTZ, IRA;
- RAJPATHAK, SWAPNIL
Publication type:
Article
1210-P: Pooled Analysis of the Safety and Efficacy of Ertugliflozin in the Elderly.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1210-P
By:
- PRATLEY, RICHARD E.;
- DAGOGO-JACK, SAMUEL;
- CHARBONNEL, BERNARD;
- PATEL, SHRITA M.;
- HICKMAN, MARY A.;
- LIU, JIE;
- TARASENKO, LISA;
- ELLISON, MISOO C.;
- GANTZ, IRA;
- TERRA, STEVEN G.
Publication type:
Article
1197-P: Two-Year Effects of Ertugliflozin on Renal Function.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1197-P
By:
- CHERNEY, DAVID;
- HEERSPINK, HIDDO L.;
- FREDERICH, ROBERT;
- MALDONADO, MARIO;
- PONG, ANNPEY;
- XU, ZHI JIN;
- LIU, JIE;
- MANCUSO, JAMES P.;
- GANTZ, IRA;
- TERRA, STEVEN G.
Publication type:
Article
2353-PUB: Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM).
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2353-PUB
By:
- LIU, JIE;
- TARASENKO, LISA;
- ELLISON, MISOO C.;
- PONG, ANNPEY;
- HUYCK, SUSAN;
- MANCUSO, JAMES P.;
- TERRA, STEVEN G.;
- GANTZ, IRA
Publication type:
Article
Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 8, p. 2042, doi. 10.1210/clinem/dgac764
By:
- Dagogo-Jack, Samuel;
- Frederich, Robert;
- Jie Liu;
- Cannon, Christopher P.;
- Shi, Harry;
- Cherney, David Z. I.;
- Cosentino, Francesco;
- Masiukiewicz, Urszula;
- Gantz, Ira;
- Pratley, Richard E.
Publication type:
Article
Cloning of Canine Gastrin cDNA's Encoding Variant Amino Acid Sequences.
Published in:
Digestion, 1990, v. 46, n. S2, p. 99, doi. 10.1159/000200372
By:
- Gantz, Ira;
- Takeuchi, Toshiyuki;
- Yamadaa, Tadataka
Publication type:
Article
NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine.
Published in:
Obesity (19307381), 2007, v. 15, n. 8, p. 2027, doi. 10.1038/oby.2007.242
By:
- Erondu, Ngozi;
- Addy, Carol;
- Kaifeng Lu;
- Mallick, Madhuja;
- Musser, Bret;
- Gantz, Ira;
- Proietto, Joseph;
- Astrup, Arne;
- Toubro, Søren;
- Rissannen, Aila M.;
- Tonstad, Serena;
- Haynes, William G.;
- Gottesdiener, Keith M.;
- Kaufman, Keith D.;
- Amatruda, John M.;
- Heymsfield, Steven B.
Publication type:
Article
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss.
Published in:
2007
By:
- Erondu, Ngozi;
- Wadden, Thomas;
- Gantz, Ira;
- Musser, Bret;
- Nguyen, Allison Martin;
- Bays, Harold;
- Bray, George;
- O'Neil, Patrick M.;
- Basdevant, Arnaud;
- Kaufman, Keith D.;
- Heymsfield, Steven B.;
- Amartruda, John M.;
- Amatruda, John M
Publication type:
journal article
Fat and Energy Partitioning: Longitudinal Observations in Leptin-treated Adults Homozygous for a Lep Mutation<sup>*</sup>.
Published in:
Obesity (19307381), 2006, v. 14, n. 2, p. 258, doi. 10.1038/oby.2006.33
By:
- Heymsfield, Steven B.;
- Fong, Tung M.;
- Gantz, Ira;
- Erondu, Ngozi
Publication type:
Article
A randomised, double-blind, trial of the safety and efficacy of omarigliptin (a once-weekly DPP-4 inhibitor) in subjects with type 2 diabetes and renal impairment.
Published in:
2017
By:
- Chacra, Antonio;
- Gantz, Ira;
- Mendizabal, Geraldine;
- Durlach, Lucila;
- O'Neill, Edward A.;
- Zimmer, Zachary;
- Suryawanshi, Shailaja;
- Engel, Samuel S.;
- Lai, Eseng
Publication type:
journal article
Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes.
Published in:
2015
By:
- Sheu, Wayne H.-H.;
- Gantz, Ira;
- Chen, Menghui;
- Suryawanshi, Shailaja;
- Mirza, Arpana;
- Goldstein, Barry J.;
- Kaufman, Keith D.;
- Engel, Samuel S.
Publication type:
journal article
A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin.
Published in:
BMC Endocrine Disorders, 2017, v. 17, p. 1, doi. 10.1186/s12902-017-0219-x
By:
- Seung-Hwan Lee;
- Gantz, Ira;
- Round, Elizabeth;
- Latham, Melanie;
- O'Neill, Edward A.;
- Ceesay, Paulette;
- Suryawanshi, Shailaja;
- Kaufman, Keith D.;
- Engel, Samuel S.;
- Eseng Lai
Publication type:
Article
Loops and Links: Structural Insights into the Remarkable Function of the Agouti-Related Protein.
Published in:
Annals of the New York Academy of Sciences, 2003, v. 994, n. 1, p. 27, doi. 10.1111/j.1749-6632.2003.tb03159.x
By:
- MILLHAUSER, GLENN L.;
- McNULTY, JOE C.;
- JACKSON, PILGRIM J.;
- THOMPSON, DARREN A.;
- BARSH, GREGORY S.;
- GANTZ, IRA
Publication type:
Article
Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV.
Published in:
Diabetes Therapy, 2021, v. 12, n. 5, p. 1279, doi. 10.1007/s13300-021-01033-x
By:
- Budoff, Matthew J.;
- Davis, Timothy M. E.;
- Palmer, Alexandra G.;
- Frederich, Robert;
- Lawrence, David E.;
- Liu, Jie;
- Gantz, Ira;
- Derosa, Giuseppe
Publication type:
Article
Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV.
Published in:
Diabetes Therapy, 2021, v. 12, n. 4, p. 1175, doi. 10.1007/s13300-021-01018-w
By:
- Strojek, Krzysztof;
- Pandey, A. Shekhar;
- Dell, Vanessa;
- Sisson, Melanie;
- Wang, Shuai;
- Huyck, Susan;
- Liu, Jie;
- Gantz, Ira
Publication type:
Article
Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials.
Published in:
Diabetes Therapy, 2020, v. 11, n. 6, p. 1347, doi. 10.1007/s13300-020-00803-3
By:
- Patel, Shrita;
- Hickman, Anne;
- Frederich, Robert;
- Johnson, Susan;
- Huyck, Susan;
- Mancuso, James P.;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
Article
SGLT2 Inhibitors and the Risk of Hospitalization for Fournier's Gangrene: A Nested Case–Control Study.
Published in:
Diabetes Therapy, 2020, v. 11, n. 3, p. 711, doi. 10.1007/s13300-020-00771-8
By:
- Wang, Tongtong;
- Patel, Shrita M.;
- Hickman, Anne;
- Liu, Xinyue;
- Jones, Philip LStJ;
- Gantz, Ira;
- Koro, Carol E.
Publication type:
Article
A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control.
Published in:
Diabetes Therapy, 2017, v. 8, n. 4, p. 793, doi. 10.1007/s13300-017-0270-7
By:
- Gantz, Ira;
- Okamoto, Taro;
- Ito, Yuka;
- Sato, Asako;
- Okuyama, Kotoba;
- O'Neill, Edward;
- Engel, Samuel;
- Lai, Eseng
Publication type:
Article
A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus.
Published in:
Diabetes Therapy, 2015, v. 6, n. 1, p. 75, doi. 10.1007/s13300-015-0094-2
By:
- Hauber, A.;
- Tunceli, Kaan;
- Yang, Jui-Chen;
- Gantz, Ira;
- Brodovicz, Kimberly;
- Alexander, Charles;
- Davies, Michael;
- Radican, Larry
Publication type:
Article
Efficacy and Safety of Intranasal Peptide YY<sub>3–36 </sub>for Weight Reduction in Obese Adults.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 5, p. 1754, doi. 10.1210/jc.2006-1806
By:
- Gantz, Ira;
- Erondu, Ngozi;
- Mallick, Madhuja;
- Musser, Bret;
- Krishna, Rajesh;
- Tanaka, Wesley K.;
- Snyder, Karen;
- Stevens, Cathy;
- Stroh, Mark A.;
- Haiyuan Zhu;
- Wagner, John A.;
- MacNeil, Douglas J.;
- Heymsfield, Steven B.;
- Amatruda, John M.
Publication type:
Article
Naturally Occurring Mutations in the Melanocortin Receptor 3 Gene Are Not Associated with Type 2 Diabetes Mellitus in French Caucasians.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 6, p. 2895, doi. 10.1210/jcem.86.6.7589
By:
- HANI, EL HABIB;
- DUPONT, SOPHIE;
- DURAND, EMMANUELLE;
- DINA, CHRISTIAN;
- GALLINA, SOPHIE;
- GANTZ, IRA;
- FROGUEL, PHILIPPE
Publication type:
Article
Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials.
Published in:
Diabetologia, 2020, v. 63, n. 6, p. 1128, doi. 10.1007/s00125-020-05133-4
By:
- Cherney, David Z. I.;
- Heerspink, Hiddo J. L.;
- Frederich, Robert;
- Maldonado, Mario;
- Liu, Jie;
- Pong, Annpey;
- Xu, Zhi J.;
- Patel, Shrita;
- Hickman, Anne;
- Mancuso, James P.;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
Article
Development of a Population Pharmacokinetic Model for Taranabant, a Cannibinoid-1 Receptor Inverse Agonist.
Published in:
AAPS Journal, 2010, v. 12, n. 4, p. 537, doi. 10.1208/s12248-010-9212-2
By:
- Li, Xiujiang (Susie);
- Nielsen, Jace;
- Cirincione, Brenda;
- Li, Hankun;
- Addy, Carol;
- Wagner, John;
- Hartford, Alan;
- Erondu, Ngozi;
- Gantz, Ira;
- Morgan, Jerry;
- Stone, Julie
Publication type:
Article
A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus.
Published in:
Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0593-8
By:
- Gantz, Ira;
- Menghui Chen;
- Suryawanshi, Shailaja;
- Ntabadde, Catherine;
- Shah, Sukrut;
- O'Neill, Edward A.;
- Engel, Samuel S.;
- Kaufman, Keith D.;
- Eseng Lai
Publication type:
Article

Found: 42